Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds

DNA bubbles illustration

A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds. . . . → Read More: Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds

Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Editing DNA

A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Measles-Rubella Patch Vaccine Shown Effective as Injection

Child receiving vaccine patch

A clinical trial shows a peel-and-stick patch device is as effective as a standard syringe injection in delivering a vaccine that protects against measles and rubella. . . . → Read More: Measles-Rubella Patch Vaccine Shown Effective as Injection

Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery

Gene therapy graphic

Two biotechnology companies are collaborating on creating genetic therapies delivered with lipid nanoscale particles using non-viral mechanisms to reach target cells. . . . → Read More: Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery

Start-Up Licenses Protein Therapy Tech, Raises $50M

Lab flasks

A new company making antibodies that degrade disease-causing proteins on and outside cell surfaces is raising $50 million in its first venture funding round. . . . → Read More: Start-Up Licenses Protein Therapy Tech, Raises $50M

Start-Up Licensing Antibody Eye Drops for Dry Eye Disease

Red-blue-green eye

An enterprise spun off from university labs is licensing its technology to a drug maker for eye drops with immune-system antibodies to treat dry eye disease. . . . → Read More: Start-Up Licensing Antibody Eye Drops for Dry Eye Disease

Business-Academic Team to Create RNA Delivery for Cancer

Vials and bottles

A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles. . . . → Read More: Business-Academic Team to Create RNA Delivery for Cancer

Human Ovary Organoid Model Demonstrated, Licensed

Ovarian organoid

A university lab created and licensed to a biotechnology company a model human ovary made of functioning cells for female reproductive health applications. . . . → Read More: Human Ovary Organoid Model Demonstrated, Licensed

Allergy Antibody Biotech Gains $40M in New Funds

Bag of peanuts

A biotechnology enterprise creating engineered antibodies to treat severe food allergies is raising $40 million in its second venture financing round. . . . → Read More: Allergy Antibody Biotech Gains $40M in New Funds

Start-Up Creating Software to Simplify Biomedical Analytics

DNA analysis graphic

A new enterprise began public operations to provide researchers with better analytical tools for making sense of mountains of complex genomics and related biomedical data. . . . → Read More: Start-Up Creating Software to Simplify Biomedical Analytics